Description

Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer has mainly relied on traditional cytotoxic drugs for years. Capecitabine, as orally-administered tablets, acts directly in intestine and drug concentration in the tumor tissues is higher than that in blood. Besides, it features flexible dose adjustments and compliant method of administration. All this has contributed to its market growth.

View Full Report at: http://www.marketresearchreports.biz/analysis/289184

Capecitabine develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 635 million in 2014 and CAGR reaching up to 25.3% during this period. Capecitabine enjoys a vast demand in China. Currently, there are mainly five manufacturers of capecitabine in China: Shanghai Roche Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd, among which Shanghai Roche Pharmaceutical Co., Ltd has the largest market share of over 95% with sales value exceeding CNY 600 million in 2014.

With the degradation of environment and lifestyle changes brought about by improved living standards, the incidence of cancer keeps increasing in China. Therefore, capecitabine has good prospects in China and its market size will keep growing.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/289184

Readers can get at least the following information from this report:

market share of manufacturers of capecitabine in China
price of capecitabine in Chinese market
major manufacturers of capecitabine in Chinese market
share of dosage forms of capecitabine in China
market outlook of capecitabine in China


The author suggests the following groups of people purchase this report:

manufacturers of antitumor drugs
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Capecitabine
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Capecitabine in China
2.1 Patent and Approval Status of Capecitabine in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Capecitabine in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]